← Evidence map

ArticleBMC immunology2025

Impact of switching from the originator adalimumab to a biosimilar: a retrospective cohort study.

W H A van Poecke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

4 papers cite it

2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 40610896